Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

402
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
402
Odds Ratio01:09

Odds Ratio

962
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
962
Censoring Survival Data01:09

Censoring Survival Data

360
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
360
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

709
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
709
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

264
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
264
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

783
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
783

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the human anellome across the lifespan reveals sex-specific biphasic trajectories.

npj aging·2026
Same author

Ribonucleotide-Modified Primer Overlapping Blocker Elongation (PROBE) Assay for Highly Specific Mutation Detection.

Analytical chemistry·2026
Same author

Development of a HiFi-LAMP assay for the detection of herpes simplex virus type 1.

Scientific reports·2026
Same author

Fe-N<sub>5</sub> single-atom sites on C<sub>3</sub>N<sub>4</sub> enable ultrasensitive electrochemical sensing of hydrogen sulfide in bone metastatic microenvironments.

Biosensors & bioelectronics·2026
Same author

Glutamate decarboxylase 1 (GAD1) suppresses the progression of glioblastoma through GSK3β/β-catenin pathway.

Cell death discovery·2026
Same author

Dysbiosis of fecal virome in pediatric Crohn's disease and its dynamic changes during infliximab therapy.

mSystems·2026

Related Experiment Video

Updated: Nov 16, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

886

Statistical Methods for Quantifying Between-study Heterogeneity in Meta-analysis with Focus on Rare Binary Events.

Chiyu Zhang1, Min Chen2, Xinlei Wang1

  • 1Department of Statistical Science, Southern Methodist University, USA.

Statistics and Its Interface
|February 25, 2021
PubMed
Summary

This study comprehensively reviews methods for estimating between-study variance (τ²) in meta-analysis, especially for rare binary events. It finds no single best method but identifies superior options for specific scenarios, offering practical guidelines.

Keywords:
DerSimonian and LairdQ statisticbiasconfidence intervalcoverage probabilityfixed effectmean squared errorodds ratiorandom effects

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K

Related Experiment Videos

Last Updated: Nov 16, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

886
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.5K

Area of Science:

  • Biostatistics
  • Medical Research Methodology

Background:

  • Meta-analysis is crucial for synthesizing medical research, but accurately estimating between-study variance (τ²) is challenging.
  • Existing comparisons of τ² estimation methods are often incomplete or outdated, particularly for rare binary events.

Purpose of the Study:

  • To provide a comprehensive overview and categorization of descriptive measures, estimators, and confidence intervals for τ².
  • To evaluate the performance of these methods using simulations, focusing on rare binary event scenarios.

Main Methods:

  • Compiled a comprehensive set of 11 descriptive measures, 23 estimators, and 16 confidence intervals for τ².
  • Conducted simulation studies to assess method performance under various realistic scenarios for rare binary events.
  • Illustrated findings with a meta-analysis example of gestational diabetes.

Main Results:

  • Identified no single universally superior method for τ² estimation.
  • Highlighted specific methods demonstrating consistently better performance for rare binary events.
  • Provided practical guidelines for selecting appropriate methods based on numerical evidence.

Conclusions:

  • The choice of τ² estimation method in meta-analysis is context-dependent, especially for rare binary events.
  • Evidence-based recommendations can guide researchers in selecting optimal methods for improved meta-analysis accuracy.